{"id":13720,"date":"2023-02-06T13:58:21","date_gmt":"2023-02-06T08:28:21","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=13720"},"modified":"2026-07-23T15:37:49","modified_gmt":"2026-07-23T10:07:49","slug":"sarm1-inhibitors-market","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/","title":{"rendered":"SARM1 Inhibitor: A Solution Against Neurodegenerative Disorders"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitor as potential therapeutic agent for the treatment of neurological disorders across various preclinical studies and early stages of clinical development, worldwide. Given the encouraging research outcomes, the players in the SARM1 inhibitor market have received more than USD 10 million in grants, since 2014, from the various private and public organizations. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Additionally, several patents related to <a href=\"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/\">SARM1 inhibitors<\/a> have been recently filed \/ granted, demonstrating the continued innovation in this domain. Driven by the ongoing pace of innovation in this field, increasing R&amp;D activity and promising pre-clinical data, several promising leads are anticipated to be commercially launched over the coming decade and <a href=\"https:\/\/www.rootsanalysis.com\/reports\/sarm1-inhibitors-market.html\">SARM1 inhibitor market<\/a> is anticipated to witness substantial growth in the mid to long-term.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">SARM1 Inhibitor: Current Market Trend<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">At present, several companies worldwide have taken initiatives to develop SARM1 inhibitor for targeting multiple neurological disorders, including multiple sclerosis and amyotrophic lateral sclerosis. The market is characterized by a mix of well-established and small firms. Currently, their pipeline features both <a href=\"https:\/\/www.rootsanalysis.com\/blog\/demand-for-outsourcing-biologics-fill-finish\/\">biologics<\/a> and small molecules drugs, which are being evaluated in preclinical and discovery stages.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Sample-list-of-SARM1-Targeting-Drugs-Roots-Analysis.webp\" alt=\"SARM1 Inhibitor: Current Market Trend\" class=\"wp-image-19784\" style=\"object-fit:contain;width:645px;height:283px\" width=\"645\" height=\"283\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Sample-list-of-SARM1-Targeting-Drugs-Roots-Analysis.webp 618w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Sample-list-of-SARM1-Targeting-Drugs-Roots-Analysis-300x132.webp 300w\" sizes=\"auto, (max-width: 645px) 100vw, 645px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\">SARM1 Inhibitor: Strong Intellectual Property Portfolio<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Over the years, the number of patents filed for SARM1 inhibitors has increased gradually; majority of the patents have been filed \/ granted in 2021. In addition, most of the patents in this domain are patent applications (96%), followed by granted patents (3%).<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Distribution-by-Patent-Valuations-CPC-Roots-Analysis.webp\" alt=\"SARM1 Inhibitor: Strong Intellectual Property Portfolio\" class=\"wp-image-19787\" style=\"object-fit:contain;width:638px;height:267px\" width=\"638\" height=\"267\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Distribution-by-Patent-Valuations-CPC-Roots-Analysis.webp 609w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Distribution-by-Patent-Valuations-CPC-Roots-Analysis-300x126.webp 300w\" sizes=\"auto, (max-width: 638px) 100vw, 638px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\">Future opportunities for SARM1 Inhibitors<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Currently, there are no potential treatment options that target axonal degeneration associated disorders. Across various studies, SARM1 inhibitor has demonstrated the potential to treat multiple neurodegenerative disorders; once approved, these therapies are likely to capture a sizeable market share in the coming future. Further, we expect the first product to be commercially launched in 2033; post that, the market is expected to grow at an annualized rate of 102%.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Market-Opportunity-Projection-SARM1-Roots-Analysis.webp\" alt=\"Future opportunities for SARM1 Inhibitors\" class=\"wp-image-19789\" style=\"object-fit:contain;width:629px;height:264px\" width=\"629\" height=\"264\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Market-Opportunity-Projection-SARM1-Roots-Analysis.webp 615w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Market-Opportunity-Projection-SARM1-Roots-Analysis-300x126.webp 300w\" sizes=\"auto, (max-width: 629px) 100vw, 629px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">You can also download the&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/sarm1-inhibitors-market\/request-sample.html\">SAMPLE REPORT<\/a>&nbsp;on SARM1 inhibitors by Roots Analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitor as potential therapeutic agent for the treatment of neurological disorders across various preclinical studies and early stages of clinical development, worldwide. Given the encouraging research outcomes, the players in the SARM1 inhibitor market have received more than USD 10 million in grants, since 2014, from [&hellip;]<\/p>\n","protected":false},"author":67,"featured_media":16420,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[119,335,612,369,257],"tags":[899,894,892,891,898],"class_list":["post-13720","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alzheimers-disease","category-alzheimers-pipeline","category-alzheimers-disease-2","category-neurodegeneration","category-parkinsons-disease","tag-common-neurological-disorders","tag-neurodegenerative-disorders","tag-sarm1","tag-sarm1-inhibitors","tag-treatment-of-neurological-disorders"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Why SARM1 Inhibitors Are Gaining Ground in Neurology<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, the first SARM1 inhibitor is to be commercialized in 2033; post that, the market is expected to grow at 102% CAGR\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders\" \/>\n<meta property=\"og:description\" content=\"At present, several companies worldwide have taken initiatives to develop SARM1 inhibitors for targeting multiple neurological disorders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-06T08:28:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T10:07:49+00:00\" \/>\n<meta name=\"author\" content=\"Rohit Pareek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders\" \/>\n<meta name=\"twitter:description\" content=\"At present, several companies worldwide have taken initiatives to develop SARM1 inhibitors for targeting multiple neurological disorders.\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rohit Pareek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/\"},\"author\":{\"name\":\"Rohit Pareek\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/6c30c36f3d821b530eb72afe813da331\"},\"headline\":\"SARM1 Inhibitor: A Solution Against Neurodegenerative Disorders\",\"datePublished\":\"2023-02-06T08:28:21+00:00\",\"dateModified\":\"2026-07-23T10:07:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/\"},\"wordCount\":324,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/RootsAnalysis_FeaturedImage_002.webp\",\"keywords\":[\"common neurological disorders\",\"neurodegenerative disorders\",\"sarm1\",\"sarm1 inhibitors\",\"treatment of neurological disorders\"],\"articleSection\":[\"Alzheimer's Disease\",\"Alzheimer's Pipeline\",\"Alzheimer\u2019s Disease\",\"Neurodegeneration\",\"Parkinson\u2019s Disease\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/\",\"name\":\"Why SARM1 Inhibitors Are Gaining Ground in Neurology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/RootsAnalysis_FeaturedImage_002.webp\",\"datePublished\":\"2023-02-06T08:28:21+00:00\",\"dateModified\":\"2026-07-23T10:07:49+00:00\",\"description\":\"According to Roots Analysis, the first SARM1 inhibitor is to be commercialized in 2033; post that, the market is expected to grow at 102% CAGR\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/RootsAnalysis_FeaturedImage_002.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/RootsAnalysis_FeaturedImage_002.webp\",\"width\":150,\"height\":150,\"caption\":\"This is a feature image for blog article SARM1 Inhibitors at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1-inhibitors-market\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SARM1 Inhibitor: A Solution Against Neurodegenerative Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/6c30c36f3d821b530eb72afe813da331\",\"name\":\"Rohit Pareek\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g\",\"caption\":\"Rohit Pareek\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why SARM1 Inhibitors Are Gaining Ground in Neurology","description":"According to Roots Analysis, the first SARM1 inhibitor is to be commercialized in 2033; post that, the market is expected to grow at 102% CAGR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/","og_locale":"en_US","og_type":"article","og_title":"SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders","og_description":"At present, several companies worldwide have taken initiatives to develop SARM1 inhibitors for targeting multiple neurological disorders.","og_url":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2023-02-06T08:28:21+00:00","article_modified_time":"2026-07-23T10:07:49+00:00","author":"Rohit Pareek","twitter_card":"summary_large_image","twitter_title":"SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders","twitter_description":"At present, several companies worldwide have taken initiatives to develop SARM1 inhibitors for targeting multiple neurological disorders.","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Rohit Pareek","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/"},"author":{"name":"Rohit Pareek","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/6c30c36f3d821b530eb72afe813da331"},"headline":"SARM1 Inhibitor: A Solution Against Neurodegenerative Disorders","datePublished":"2023-02-06T08:28:21+00:00","dateModified":"2026-07-23T10:07:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/"},"wordCount":324,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_FeaturedImage_002.webp","keywords":["common neurological disorders","neurodegenerative disorders","sarm1","sarm1 inhibitors","treatment of neurological disorders"],"articleSection":["Alzheimer's Disease","Alzheimer's Pipeline","Alzheimer\u2019s Disease","Neurodegeneration","Parkinson\u2019s Disease"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/","url":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/","name":"Why SARM1 Inhibitors Are Gaining Ground in Neurology","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_FeaturedImage_002.webp","datePublished":"2023-02-06T08:28:21+00:00","dateModified":"2026-07-23T10:07:49+00:00","description":"According to Roots Analysis, the first SARM1 inhibitor is to be commercialized in 2033; post that, the market is expected to grow at 102% CAGR","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_FeaturedImage_002.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/09\/RootsAnalysis_FeaturedImage_002.webp","width":150,"height":150,"caption":"This is a feature image for blog article SARM1 Inhibitors at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"SARM1 Inhibitor: A Solution Against Neurodegenerative Disorders"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/6c30c36f3d821b530eb72afe813da331","name":"Rohit Pareek","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g","caption":"Rohit Pareek"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=13720"}],"version-history":[{"count":18,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13720\/revisions"}],"predecessor-version":[{"id":20426,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13720\/revisions\/20426"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/16420"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=13720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=13720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=13720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}